Navigation Links
Kerafast Adds New Zika Virus Antibody to Its Catalog of Novel Life Science Reagents
Date:5/3/2016

Kerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced the availability of a Zika virus antibody from Vanderbilt University.

While researchers scramble to increase the pace of research toward treatment and prevention measures for the Zika virus, the virus’s geographical distribution continues to widen during this epidemic. Thought to be the cause of microcephaly in newborn babies, the disease is spread by the mosquito genus Aedes as well as by sexual contact.

By sharing data and materials research institutions can help to address the current Zika outbreak and minimize its effects on the global population. “Progress in the field of infectious disease is predicated on the availability of critical reagents, many of which can be difficult to source. We wanted to supply this Zika antibody to the global research community as quickly as possible,” said Alan Bentley, who heads up Vanderbilt University’s Center for Technology Transfer and Commercialization.

Kerafast is constantly adding new research materials to its online collection that are available for purchase through a user-friendly and straightforward research-use-only “click license.” The Zika polyclonal antibody recognizes the human Zika envelope (E) protein and can be utilized for a range of applications to study the virus and its function.

“At Kerafast, our mission promotes access to rare and unique research reagents by facilitating a community of both Providing and Procuring laboratories that work toward the cure of disease,” said Dr. Robert Bondaryk, CEO. “We hope by making this Zika virus antibody available in our catalog we are helping to progress research toward a vaccine, treatment and cure for this worldwide health crisis.”

About Kerafast, Inc.
Since its founding in 2011, Kerafast has partnered with more than 130 prominent academic research institutions internationally that provide thousands of rare and unique ‘Reagents for the Greater Good’ for the benefit of the scientific community working toward the cure of disease in 52 countries on 6 continents. Visit kerafast.com for more information.

Contact:
Jennifer M. Rossi, Ph.D.    
Chief Operating Officer
Kerafast Inc.
617.982.7069
jennifer(dot)rossi(at)kerafast(dot)com

Read the full story at http://www.prweb.com/releases/KerafastAnnounces/ZikaAntibody/prweb13385521.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. DiaCarta Inc. Receives CE Mark for QuantiVirus® HPV E6/E7 mRNA Assay
2. Highly lethal Ebola virus has diagnostic Achilles heel for biothreat detection, scientists say
3. Antimicrobial Test Laboratories Emerges as Leading Provider of Virus Testing Services
4. Global Virus Network Opens Headquarters in the University of Maryland BioPark
5. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
6. Study puts troubling traits of H7N9 avian flu virus on display
7. Redbiotec and TeselaGen to Partner on Herpesvirus Vaccine Library
8. NanoBio To Present Data At ICAAC Supporting The Development Of Safe And Effective RSV & Herpes Simplex Virus-2 Vaccines
9. West Nile Virus Reported from New York to Long Beach; The Center for the Biology of Chronic Disease (CBCD) Urges the Public to Take Precautions
10. UCLA researchers smartphone microscope can detect a single virus, nanoparticles
11. Hitchhiking virus confirms saga of ancient human migration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2019)... ... January 08, 2019 , ... ... spinal implant company, announced today that SAGICO will be represented at the ... annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare ...
(Date:1/8/2019)... ... ... The American Society of Gene and Cell Therapy’s (ASGCT) first ... up of industry leaders identified by the ASGCT board of directors. In total, the ... support ASGCT members designing transformative pilot studies in gene and cell therapy as they ...
(Date:1/4/2019)... ... January 01, 2019 , ... uBiome, the leader in microbial ... Annual Meeting January 22-25, 2019 held in Davos-Klosters, Switzerland following their selection as ... Annual Meeting brings together leaders of global society–the heads and members of more ...
(Date:12/20/2018)... ... ... New Year’s brings reflection and desire to improve for individuals and businesses ... on the horizon, Jim Kasic, president and CEO of Boulder iQ, suggests five resolutions ... Regulation (MDR), digital health, and big data are just a few of the challenges ...
Breaking Biology Technology:
(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/22/2018)... ... December 21, 2018 , ... ... and hosted the Boston Healthcare Drinks event featuring Helen Chen, Greater China Managing ... China.” , The discussion was moderated by patent attorney David J. Dykeman ...
(Date:12/18/2018)... ... December 18, 2018 , ... The nation’s leader in ... marketing. The technology has been effective at reducing patient acquisition costs by over ... with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem cell ...
Breaking Biology News(10 mins):